USANA Health Sciences (NYSE:USNA) Stock Price Up 3.4% – Still a Buy?

USANA Health Sciences, Inc. (NYSE:USNA)’s stock price traded up 3.4% during mid-day trading on Monday . The stock traded as high as $32.77 and last traded at $32.87. 32,805 shares traded hands during mid-day trading, a decline of 75% from the average session volume of 130,944 shares. The stock had previously closed at $31.78.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on USNA shares. StockNews.com lowered shares of USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a report on Friday, February 14th. Sidoti downgraded shares of USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, February 18th. Finally, DA Davidson increased their price target on shares of USANA Health Sciences from $35.00 to $38.00 and gave the stock a “neutral” rating in a research report on Thursday, January 2nd.

USANA Health Sciences Trading Up 3.6 %

The business’s 50 day moving average is $33.81 and its 200 day moving average is $36.73. The stock has a market capitalization of $627.65 million, a PE ratio of 11.57, a PEG ratio of 0.93 and a beta of 0.87.

Institutional Investors Weigh In On USANA Health Sciences

Large investors have recently modified their holdings of the business. Creative Planning purchased a new stake in USANA Health Sciences during the third quarter worth $394,000. Allspring Global Investments Holdings LLC boosted its position in USANA Health Sciences by 14,068.2% during the third quarter. Allspring Global Investments Holdings LLC now owns 38,821 shares of the company’s stock valued at $1,472,000 after purchasing an additional 38,547 shares in the last quarter. Assenagon Asset Management S.A. grew its stake in USANA Health Sciences by 13.5% in the third quarter. Assenagon Asset Management S.A. now owns 124,008 shares of the company’s stock valued at $4,702,000 after purchasing an additional 14,756 shares during the last quarter. Harbor Capital Advisors Inc. raised its holdings in USANA Health Sciences by 44.1% in the third quarter. Harbor Capital Advisors Inc. now owns 8,859 shares of the company’s stock worth $336,000 after purchasing an additional 2,713 shares in the last quarter. Finally, KBC Group NV lifted its position in shares of USANA Health Sciences by 96.6% during the third quarter. KBC Group NV now owns 1,056 shares of the company’s stock valued at $40,000 after buying an additional 519 shares during the last quarter. Institutional investors own 54.25% of the company’s stock.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.